-
EP3087972
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3087972
| EP3087972 - TOPICAL FORMULATION FOR A JAK INHIBITOR [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.10.2017 Database last updated on 22.05.2024 | |
| Former | Request for examination was made Status updated on 15.06.2017 | Most recent event Tooltip | 13.10.2017 | Application deemed to be withdrawn | published on 15.11.2017 [2017/46] | Applicant(s) | For all designated states Incyte Holdings Corporation 1801 Augustine Cut-Off Wilmington, DE 19803 / US | [2016/44] | Inventor(s) | 01 /
PARIKH, Bhavnish 120 Portmarnock Drive Avondale, PA Pennsylvania 19311 / US | 02 /
SHAH, Bhavesh 24907 Flying Arrow San Antonio, TX Texas 78258 / US | 03 /
YELESWARAM, Krishnaswamy 136 Harrogate Drive Landenberg, PA Pennsylvania 19350 / US | [2016/44] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2016/44] | Application number, filing date | 16160077.0 | 20.05.2011 | [2016/44] | Priority number, date | US20100347132P | 21.05.2010 Original published format: US 347132 P | [2016/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3087972 | Date: | 02.11.2016 | Language: | EN | [2016/44] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.09.2016 | Classification | IPC: | A61K9/107, A61K31/519, A61K47/10, A61K9/00, A61K47/06, A61K47/14, A61K47/24, A61K47/36, A61K47/26 | [2016/44] | CPC: |
A61K31/519 (EP,CN,EA,KR,US);
A61K9/107 (EP,CN,EA,KR,US);
A61K47/06 (EP,CN,EA,KR,US);
A61K47/10 (EA,KR,US);
A61K47/14 (KR,US);
A61K47/18 (CN);
A61K47/24 (KR,US);
A61K47/26 (US);
A61K47/36 (CN,KR,US);
A61K9/00 (EA);
A61K9/0014 (EP,CN,KR,US);
A61K9/06 (US);
A61P17/00 (EP,KR,US);
A61P17/02 (EP);
A61P17/04 (EP);
A61P17/06 (EP,KR,US);
A61P37/02 (EP);
A61P37/08 (EP);
A61P43/00 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/23] |
| Former [2016/44] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 02.05.2017 | ME | 02.05.2017 | Title | German: | TOPISCHE FORMULIERUNG FÜR EINEN JAK-HEMMER | [2016/44] | English: | TOPICAL FORMULATION FOR A JAK INHIBITOR | [2016/44] | French: | FORMULATION TOPIQUE POUR UN INHIBITEUR JAK | [2016/44] | Examination procedure | 14.03.2016 | Date on which the examining division has become responsible | 02.05.2017 | Examination requested [2017/23] | 03.05.2017 | Application deemed to be withdrawn, date of legal effect [2017/46] | 19.06.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2017/46] | Parent application(s) Tooltip | EP11724104.2 / EP2574168 | Fees paid | Renewal fee | 14.03.2016 | Renewal fee patent year 03 | 14.03.2016 | Renewal fee patent year 04 | 14.03.2016 | Renewal fee patent year 05 | 14.03.2016 | Renewal fee patent year 06 | 30.05.2017 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2009158687 (ANTERIOS INC [US], et al) [X] 1-5,7-13,15-19,21,22,24-28 * paragraph [0123]; claims 28, 172, 181, 225 * * paragraphs [0183] , [ 254] *[I] 6,14,20,23 | by applicant | US5521184 | WO0009495 | WO0053595 | WO0114402 | WO0164655 | WO03024967 | WO03037347 | WO03099771 | WO2004005281 | WO2004046120 | WO2004056786 | WO2004080980 | WO2005028444 | WO2006056399 | - ORTMANN, R. A.; T. CHENG ET AL., ARTHRITIS RES, (2000), vol. 2, no. 1, pages 16 - 32 | - RODIG, S. J.; M. A. MERAZ, CELL, (1998), vol. 93, no. 3, pages 373 - 383 | - BOUDNY, V.; KOVARIK, J., NEOPLASM., (2002), vol. 49, pages 349 - 355 | - BOWMAN, T. ET AL., ONCOGENE, (2000), vol. 19, pages 2474 - 2488 | - GOTTLIEB, A.B. ET AL., NAT REV DRUG DISC., vol. 4, pages 19 - 34 | - JCI, vol. 113, pages 1664 - 1675 | - ADV PHARMACOL., (2000), vol. 47, pages 113 - 174 | - Remington's Pharmaceutical Sciences, MACK PUBLISHING COMPANY, (1985), page 1418 | - JOURNAL OF PHARMACEUTICAL SCIENCE, (1977), vol. 66, page 2 | - AUNGST B, "Fatty Acid Skin Penetration Enhanccrs", PHARM. RES., (1989), vol. 6, no. 3, pages 244 - 247 |